India’s first COVID-19 vaccine gets DCGI approval for human trials
India's 'first' indigenous COVID-19 vaccine COVAXIN has got the nod for human clinical trials from the Drug Controller General of India (DGCI).
- Sponsored -
- Sponsored -
- Sponsored -